On November 27, the Subject Expert Committee on COVID-19 had evaluated and deliberated on SII’s application and sought additional data from the company. An expert panel of the country’s central drug authority has recommended granting emergency use authorisation to Serum Institute of India’s COVID-19 vaccine ‘Covovax’ with certain conditions, official sources said on Monday. Prakash … Read more
“Noting that the vaccine is technology transfer of Novavax vaccine, DCGI has sought to know the approval status of the application with regulatory authorities in the country of origin, that is the USA. The Drugs Controller General of India (DCGI) has raised queries and sought more data from Serum Institute of India over its application … Read more
Adar Poonawalla, the CEO of Serum Institute of India (SII), hailed WHO’s decision as “yet another milestone” in the fight against COVID-19. The World Health Organisation on Friday issued emergency use listing for anti-Covid vaccine Covovax produced by Serum Institute of India under licence from Novavax, expanding the basket of jabs validated by the global … Read more
The European Medicines Agency is also evaluating the company’s application for conditional marketing authorisation for Novavax’s vaccine, which will be marketed in the European Union under the brand name Nuvaxovid. The World Health Organization (WHO) will hold a meeting next week to consider emergency use listing of Serum Institute of India’s (SII) Covid-19 vaccine Covovax. … Read more
If caution is thrown to the wind, we could well be laying out an invitation for a second wave, which the country can ill afford. (PTI Photo/File) If there are reasons for India to take comfort in the declining new cases of the COVID-19 virus, there are equal reasons, if not more, for it to … Read more
Almost all the major platforms to make the vaccines are being carried out in India by at least half a dozen leading Indian vaccine companies and many smaller companies. (AP photo) While the rich nations are facing shortages of COVID-19 vaccines despite their aggressive procurement plans and with the hope of getting the bulk of … Read more
Covishield-maker Serum Institute applies to begin trials of its second COVID-19 vaccine Covovax: The announcement comes a day after Novovax Inc said that its Covid-19 vaccine Covovax was 89.3% effective in preventing Covid-19 in a trial conducting in the United Kingdom.(Representational image; Reuters/File Photo) Serum Institute to begin trial of second Covid-19 vaccine: Makers of … Read more